Imprimis NJOF, LLC: Drug Recall

Recall #D-0476-2024 · 04/10/2024

Class II: Risk

Recall Details

Recall Number
D-0476-2024
Classification
Class II
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Ongoing
Date Initiated
04/10/2024
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3320 bottles

Reason for Recall

Subpotent Drug

Product Description

Prednisolone Sodium Phosphate-Moxifloxacin-Bromfenac Sterile Ophthalmic Solution 1%, 0.5%, 0.075%, 8mL, Compounded By: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ 07852, NDC 71384-340-08

Distribution Pattern

U.S. Nationwide

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.